Abstract
The transcription factor E2F activates genes required for S phase, such as cyclin E and cyclin A. We show that, contrary to long term effects of E2F-1 overexpression, short ectopic overexpression of this transcription factor in logarithmically growing cells does neither affect the cell cycle distribution nor the cell size, but heavily induces cyclin E and A expression as well as cyclin E- and A-dependent kinase activities. We further separated logarithmically growing E2F-1-overexpressing cells according to their different cell cycle phases by centrifugal elutriation. These experiments revealed that deregulated E2F-1 expression triggers high levels of cyclin E and A expression and kinase activities in small early G1 cells, normally not exhibiting these activities. These effects on the regulation of cyclin E- and A-associated kinases are not accompanied by any detectable alteration in the rate of progression through the cell cycle, suggesting that these changes are independent of any mitogenic properties of E2F-1.
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Soucek, T., Pusch, O., Hengstschläger-Ottnad, E. et al. Deregulated expression of E2F-1 induces cyclin A- and E-associated kinase activities independently from cell cycle position. Oncogene 14, 2251–2257 (1997). https://doi.org/10.1038/sj.onc.1201061
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1201061
- Springer Nature Limited
Keywords
This article is cited by
-
Reconstruction of pathway modification induced by nicotinamide using multi-omic network analyses in triple negative breast cancer
Scientific Reports (2017)
-
Silence on the relevant literature and errors in implementation
Nature Biotechnology (2015)
-
EpCAM regulates cell cycle progression via control of cyclin D1 expression
Oncogene (2013)
-
Cyclin A2
AfCS-Nature Molecule Pages (2007)
-
E2F-1, Skp2 and cyclin E oncoproteins are upregulated and directly correlated in high-grade neuroendocrine lung tumors
Oncogene (2007)